Epigenetic studies in lung cancer have shown that promoter regions of the CTLA-4, PD-1, and PDL-1 genes can be hypomethylated, which in turn associates with upregulated expression of these genes in the tumor microenvironment (Marwitz et al., 2017). The gene discussed is CD274; the disease is lung carcinoma.